Evidence map›Paper›PMID 19477947›Full record

ArticleThe American journal of pathology2009

Paradoxical effects of PDGF-BB overexpression in endothelial cells on engineered blood vessels in vivo.

Patrick Au, Joshua Tam, Dan G Duda, Pei-Chun Lin, Lance L Munn, Dai Fukumura, Rakesh K Jain

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 43 citations in OpenAlex.

  1. Human endothelial colony-forming cells serve as trophic mediators for mesenchymal stem cell engraftment via paracrine signaling.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. 3D tumor angiogenesis models: recent advances and challenges.Journal of cancer research and clinical oncology · 2021
    Review
  8. Article
  9. Article
  10. Cell seeding accelerates the vascularization of tissue engineering constructs in hypertensive mice.Hypertension research : official journal of the Japanese Society of Hypertension · 2021
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Pericyte-derived MFG-E8 regulates pathologic angiogenesis.Arteriosclerosis, thrombosis, and vascular biology · 2011
    Article
  19. Article
  20. Spontaneous nonthymic tumors in SCID mice.Comparative medicine · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Patrick AuDepartment of RadiationOncology, Edwin L Steele Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
Joshua Tam
Dan G Duda
Pei-Chun Lin
Lance L Munn
Dai Fukumura
Rakesh K Jain
Massachusetts General Hospital · USHarvard University · US

Funding

Vascular Normalization: Rolse of Perivascular CellsP01CA080124 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI JAIN, RAKESH K. · 2000 to 2016
$35.0M
Integrative Biology of Tumor MetastasisR01CA085140 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI JAIN, RAKESH K. · 2005 to 2009
$8.6M
BIOLOGY OF TUMOR ANGIOGENESIS, INVASION AND METASTASISR24CA085140 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI JAIN, RAKESH K. · 2000 to 2004
$8.3M
Probing Tumor Microenvironment Using NanotechnologyR01CA126642 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI JAIN, RAKESH K. · 2008 to 2012
$8.3M
NO in Tumor Angiogenesis,Microcirculation &Rad.TherapyR01CA096915 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI FUKUMURA, DAI · 2002 to 2012
$3.0M
Training Program in Pathophysiology of Solid TumorsT32CA073479 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI JAIN, RAKESH K. · 1998 to 2012
$3.0M
Role of BMDCs in Solid Tumor Growth and RelapseR01CA115767 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI JAIN, RAKESH K. · 2006 to 2010
$2.2M
NCI NIH HHS P01 CA080124NCI NIH HHS P01-CA80124NCI NIH HHS R01 CA085140NCI NIH HHS R01 CA096915NCI NIH HHS R01 CA115767NCI NIH HHS R01-CA115767NCI NIH HHS R01 CA126642NCI NIH HHS R01-CA126642NCI NIH HHS R01-CA85140NCI NIH HHS R01-CA96915NCI NIH HHS R24 CA085140NCI NIH HHS T32 CA073479
6 · The paper itself

Abstract

Therapeutic revascularization with either exogenous angiogenic growth factors or vascular cells has yet to demonstrate efficacy in the clinic. Injection of angiogenic growth factors often produces unstable and abnormal blood vessels. Blood vascular networks derived from implanted endothelial cells persist only transiently due to the insufficient recruitment of perivascular cells. We hypothesize that a combination of the two approaches may act synergistically to yield a better result. To enhance the recruitment of perivascular cells, human umbilical vein endothelial cells were genetically modified to overexpress platelet-derived growth factor (PDGF)-BB. PDGF-BB overexpression promoted both proliferation and migration of perivascular precursor cells (10T1/2 cells) in vitro. When mock-infected endothelial cells were implanted alone in vivo, they formed transient blood vascular networks that regressed by day 30. PDGF-BB overexpression enhanced the survival of endothelial cells in vivo. However, the PDGF-BB-expressing vessel network failed to establish patent blood flow. Co-implantation of PDGF-BB-overexpressing endothelial cells with 10T1/2 cells paradoxically resulted in the rapid regression of the vascular networks in vivo. PDGF-BB stimulated the expression of both chemokine (C-C motif) ligand 2 (CCL2) and CCL7 in 10T1/2 cells and led to the increased accumulation of macrophages in vivo. These results suggest a potential negative interaction between angiogenic growth factors and vascular cells; their use in combination should be carefully tested in vivo for such opposing effects.

Indexed as

AnimalsBecaplerminBlood VesselsBlotting, WesternCell MovementCell ProliferationCell SurvivalChemokine CCL2Chemokine CCL7Endothelial CellsEnzyme-Linked Immunosorbent AssayHumansIn Situ Nick-End LabelingMiceMice, SCIDNeovascularization, PhysiologicBecaplerminChemokine CCL2Chemokine CCL7Platelet-Derived Growth FactorProto-Oncogene Proteins c-sis

Identifiers

PMID19477947
PMCPMC2708815
OpenAlexW2081167583

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.